311: Fauci's Memoir, Alnylam's Tenuous Trial, And A Mid-year Review The Readout Loud podcast

Artwork

Indhold leveret af STAT. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af STAT eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

The Readout Loud « »
311: Fauci's memoir, Alnylam's tenuous trial, and a mid-year review

4M ago 34:10

Del

MP3•Episode hjem

Indhold leveret af STAT. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af STAT eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

STAT reporter Jason Mast joins us to discuss Anthony Fauci's memoir "On Call," which was published this week. Hosts Allison DeAngelis and Adam Feuerstein also dissect Alnylam's forthcoming clinical trial data and take stock of how the biotech markets are succeeding and potentially falling flat midway through the year.

For more on Fauci's memoir "On Call," go here; for Adam's primer on Alnylam's ATTR-CM trial, go here; read about BridgeBio's plans here; and for more on biotech startup financing, go here.

… continue reading

331 episoder

#Business #Stats

Artwork

311: Fauci's memoir, Alnylam's tenuous trial, and a mid-year review

The Readout Loud

published 4M ago

Del

MP3•Episode hjem

Indhold leveret af STAT. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af STAT eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

STAT reporter Jason Mast joins us to discuss Anthony Fauci's memoir "On Call," which was published this week. Hosts Allison DeAngelis and Adam Feuerstein also dissect Alnylam's forthcoming clinical trial data and take stock of how the biotech markets are succeeding and potentially falling flat midway through the year.

For more on Fauci's memoir "On Call," go here; for Adam's primer on Alnylam's ATTR-CM trial, go here; read about BridgeBio's plans here; and for more on biotech startup financing, go here.

… continue reading

331 episoder

#Business #Stats

Tutti gli episodi

×

Velkommen til Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

Lyt til 500+ emner